Follow
Andrew Hill
Andrew Hill
Unknown affiliation
Verified email at bulmorewriting.com
Title
Cited by
Cited by
Year
Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid and biofuel production
J Blazeck, A Hill, L Liu, R Knight, J Miller, A Pan, P Otoupal, HS Alper
Nature communications 5 (1), 3131, 2014
5702014
Overcoming gene-delivery hurdles: physiological considerations for nonviral vectors
AB Hill, M Chen, CK Chen, BA Pfeifer, CH Jones
Trends in biotechnology 34 (2), 91-105, 2016
1702016
Metabolic engineering of Yarrowia lipolytica for itaconic acid production
J Blazeck, A Hill, M Jamoussi, A Pan, J Miller, HS Alper
Metabolic engineering 32, 66-73, 2015
1452015
Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold
N Gera, AB Hill, DP White, RG Carbonell, BM Rao
PloS one 7 (11), e48928, 2012
772012
Phenotypic variation during biofilm formation: implications for anti-biofilm therapeutic design
M Beitelshees, A Hill, CH Jones, BA Pfeifer
Materials 11 (7), 1086, 2018
692018
Expanding the metabolic engineering toolbox with directed evolution
J Abatemarco, A Hill, HS Alper
Biotechnology journal 8 (12), 1397-1410, 2013
512013
Directed vaccination against pneumococcal disease
Y Li, A Hill, M Beitelshees, S Shao, JF Lovell, BA Davidson, PR Knight III, ...
Proceedings of the National Academy of Sciences 113 (25), 6898-6903, 2016
482016
Improving global vaccine accessibility
AB Hill, C Kilgore, M McGlynn, CH Jones
Current opinion in biotechnology 42, 67-73, 2016
422016
Comprehensive vaccine design for commensal disease progression
CH Jones, G Zhang, R Nayerhoda, M Beitelshees, A Hill, P Rostami, Y Li, ...
Science Advances 3 (10), e1701797, 2017
322017
In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector
Y Li, M Beitelshees, L Fang, A Hill, MK Ahmadi, M Chen, BA Davidson, ...
Science Advances 2 (7), e1600264, 2016
272016
Contemporary approaches for nonviral gene therapy
CH Jones, A Hill, M Chen, BA Pfeifer
Discovery medicine 19 (107), 447, 2015
232015
Engineering a Next-Generation Glycoconjugate-Like Streptococcus pneumoniae Vaccine
AB Hill, M Beitelshees, R Nayerhoda, BA Pfeifer, CH Jones
ACS infectious diseases 4 (11), 1553-1563, 2018
212018
Yarrowia lipolytica as a cell factory for oleochemical biotechnology
KA Markham, L Cordova, A Hill, HS Alper
Consequences of microbial interactions with hydrocarbons, oils, and lipids …, 2017
192017
Pressing diseases that represent promising targets for gene therapy
M Beitelshees, A Hill, P Rostami, CH Jones, BA Pfeifer
Discovery medicine 24 (134), 313, 2017
122017
Vaccine delivery and immune response basics
A Hill, M Beitelshees, BA Pfeifer
Vaccine Delivery Technology: Methods and Protocols, 1-8, 2021
112021
Scaffold diversification enhances effectiveness of a superlibrary of hyperthermophilic proteins
M Hussain, N Gera, AB Hill, BM Rao
ACS Synthetic Biology 2 (1), 6-13, 2013
102013
Compositions and methods for lipid production
J Blazeck, A Hill, L Liu, H Alper
US Patent 9,896,691, 2018
92018
Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid and biofuel production. Nat Commun 2014; 5: 3131
J Blazeck, A Hill, L Liu, R Knight, J Miller, A Pan
6
Liposomal Dual Delivery of Both Polysaccharide and Protein Antigens
R Nayerhoda, A Hill, BA Pfeifer
Vaccine Delivery Technology: Methods and Protocols, 477-487, 2021
52021
Design variation of a dual-antigen liposomal vaccine carrier system
R Nayerhoda, A Hill, M Beitelshees, C Jones, B Pfeifer
Materials 12 (17), 2809, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–20